Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 161
Filter
1.
Zentralbl Gynakol ; 124(2): 135-6, 2002 Feb.
Article in German | MEDLINE | ID: mdl-11935502

ABSTRACT

A 101-year-old patient presented with uterine myomatosis and bleeding associated with a large hematometra. An abdominal hysterectomy with adnexectomy was performed following an in-depth consultation with the patient and her daughter. The patient was discharged on the 12(th) postoperative day after a complication-free course. This case report demonstrates not only the current possibilities in the gynecological treatment of very old patients but also the hidden reserves in the gynecological care ot these women.


Subject(s)
Hematometra/surgery , Leiomyoma/surgery , Uterine Neoplasms/surgery , Aged , Aged, 80 and over , Female , Follow-Up Studies , Hematometra/pathology , Humans , Hysterectomy , Leiomyoma/pathology , Uterine Neoplasms/pathology
2.
Br J Clin Pharmacol ; 52(6): 708-10, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11736885

ABSTRACT

AIMS: The excretion of low molecular weight heparin (LMWH) in breast milk was investigated in 15 lactating mothers after Caesarean section. METHODS: Blood and milk samples were collected before and 3-4 h after once daily routine subcutaneous injection of 2500 IU dalteparin. Anti-Xa activity was measured by an assay utilizing prolonged clotting times in plasma or breast milk as an index of LMWH activity. RESULTS: Plasma anti-Xa activities ranged from 0.074 to 0.308 IU ml(-1) of plasma. Anti-Xa activities in breast milk ranged from < 0.005-0.037 IU ml(-1) of milk. This is equivalent to a milk/plasma ratio of < 0.025-0.224. CONCLUSIONS: Therefore, it appears highly unlikely that puerperal thromboprophylaxis with LMWH has any clinically relevant effect on the nursing infant.


Subject(s)
Anticoagulants/pharmacokinetics , Dalteparin/pharmacokinetics , Milk, Human/metabolism , Anticoagulants/administration & dosage , Cesarean Section , Dalteparin/administration & dosage , Factor Xa/metabolism , Female , Humans , Injections, Subcutaneous , Lactation , Postpartum Period , Time Factors
3.
J Psychosom Res ; 50(2): 87-93, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11274665

ABSTRACT

OBJECTIVES: Deliberate self-harm (DSH) patients, despite their risk of suicide, are often discharged directly from accident and emergency (A&E) departments without undergoing a psychiatric assessment. The aims of this study were to determine the characteristics and outcome of these patients. METHODS: The characteristics of DSH patients who were discharged directly from an A&E department over a 2-year period were investigated, comparing those who had a psychiatric assessment with those who did not. In a matched control design, the outcome of a group of patients who did not receive a psychiatric assessment was compared with that of a group of patients who were assessed. RESULTS: Of DSH patients who were discharged directly from the A&E department 58.9% (145/246) did not have a psychiatric assessment. Nonassessed patients were more likely to have a past history of DSH, to be in the 20-34 year age group, and to have exhibited difficult behaviour in the A&E department. Patients presenting between 5 p.m. and 9 a.m. were less likely to be assessed than those attending between 9 a.m. and 5 p.m. Further DSH during the subsequent year occurred in 37.5% of the nonassessed patients compared with 18.2% of matched assessed patients. They were also more likely to have psychiatric treatment. CONCLUSION: A substantial proportion of DSH patients discharged directly from A&E departments do not receive a psychiatric assessment. Nonassessed patients may be at greater risk of further DSH and completed suicide than those who are assessed. Hospital services need to be organised such that DSH patients managed in A&E departments can receive an assessment of psychosocial problems and risk.


Subject(s)
Emergency Services, Psychiatric , Mental Disorders/diagnosis , Mental Health Services/supply & distribution , Patient Discharge , Self-Injurious Behavior/psychology , Self-Injurious Behavior/rehabilitation , Suicide, Attempted/statistics & numerical data , Adult , Female , Follow-Up Studies , Humans , Male , Mental Disorders/psychology , Psychiatric Status Rating Scales , Risk Factors , Time Factors
4.
Exp Cell Res ; 257(1): 223-9, 2000 May 25.
Article in English | MEDLINE | ID: mdl-10854071

ABSTRACT

Cripto-1 (CR-1), a member of the EGF-CFC peptide family, plays an essential role during mesoderm formation in vertebrates as well as in cancer development. Using cDNA gene expression array, Western blot, and indirect immunofluorescence, an increase in vimentin expression was demonstrated in CR-1-transfected human Caski cervical carcinoma cells compared to control vector-transfected cells. In parental Caski cells, recombinant CR-1 induced a dose-dependent increase of vimentin protein expression within 24 h. Since vimentin expression has been demonstrated to correlate with a more aggressive phenotype in human cervical cancer, the migration capacity of CR-1-transfected or CR-1-treated Caski cells was studied in the Boyden chamber assay. Compared to the vector-transfected or untreated Caski cells, CR-1-transfected cells or cells treated with recombinant CR-1 exhibit enhanced migration, both through collagen- and through gelatin-coated membranes. Additionally, CR-1 can function as a chemoattractant for Caski cells. These findings are of biological significance since CR-1 is overexpressed in several types of human carcinomas. The present data demonstrate that CR-1 can increase vimentin expression and modulate migration in human cervical carcinoma cells.


Subject(s)
Cell Movement , Epidermal Growth Factor , Neoplasm Proteins/metabolism , Uterine Cervical Neoplasms/metabolism , Uterine Cervical Neoplasms/pathology , Vimentin/biosynthesis , Female , GPI-Linked Proteins , Humans , Intercellular Signaling Peptides and Proteins , Membrane Glycoproteins/metabolism , Tumor Cells, Cultured
5.
J Recept Signal Transduct Res ; 20(1): 1-46, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10711495

ABSTRACT

EGF-related peptides and their receptors play an important, but not fully understood role, both, in epithelial physiology and pathophysiology but also in human tumor carcinogenesis and tumor behavior, respectively. Overexpression of EGF-related growth factors from normal epithelium to carcinomas has been demonstrated for several human tissues such as breast, endometrium, cervix and ovary. Additionally, the differential overexpression of EGFR or erb B-2 in various malignancies has already proven to be efficacious in stratifying patients with respect to a poor prognosis. These data suggest that EGF-related growth factors, erb B receptors or signaling proteins that function either upstream or downstream from these receptors may represent novel targets for selective tumor therapy. In the future, conventional chemotherapy regimes will ultimately be wedded to more biologically-oriented therapies. One important target for these novel therapeutic approaches in solid tumors will be the EGF-related growth factors and their receptors.


Subject(s)
Epidermal Growth Factor/analysis , ErbB Receptors/analysis , Genital Neoplasms, Female/chemistry , Receptor, ErbB-2/analysis , Transforming Growth Factor alpha/analysis , Animals , Epidermal Growth Factor/genetics , Epidermal Growth Factor/physiology , ErbB Receptors/genetics , ErbB Receptors/physiology , Female , Genital Neoplasms, Female/diagnosis , Genital Neoplasms, Female/therapy , Humans , RNA, Messenger/analysis , Receptor, ErbB-2/genetics , Receptor, ErbB-2/physiology , Transforming Growth Factor alpha/genetics , Transforming Growth Factor alpha/physiology
6.
Horm Metab Res ; 32(1): 20-5, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10727009

ABSTRACT

The serum concentration of active glucocorticosteroids depends not only on adrenal synthesis but also on enzymatic activation of 11-dehydro-glucocorticoids in the liver by 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1). In order to define the respective involvement of other regulative enzymes in the metabolism of 11-dehydro-glucocorticoids in the liver, the objective of this study was to evaluate the kinetic behavior of NADPH:delta 4-3-ketosteroid-5alpha-reductase (5alpha-reductase, EC 1.3.99.5). The interrelations to liver 11beta-HSD1 will be discussed. The kinetic properties of 5alpha-reductase of the rabbit liver were measured by a radioenzymatic assay and characterized with respect to protein-, substrate-, cosubstrate-, and pH-dependence. Michaelis-Menten enzyme kinetic parameters (Km and Vmax) were obtained for the formation of 5alpha-reduced 11-dehydrocorticosterone and corticosterone metabolites. We found that both 11-dehydrocorticosterone (Km 4.2 x 10(-6) mol/l, Vmax 2,600 pmol x min(-1) x mg(-1)) and corticosterone (Km 0.5 x 10(-6) mol/l, Vmax 38 pmol x min(-1) x mg(-1)) exhibit a high affinity to 5alpha-reductase. With respect to cosubstrate-, pH-dependence and finasteride inhibition, it is likely that 11-dehydrocorticosterone metabolism is primarily controlled by isoenzyme 5alpha-reductase type 1. This study shows that the deactivation of GCS especially of 11-dehydro-glucocorticoids via 5alpha-reductase is an important metabolic pathway in the liver. The metabolic activation of GCS by 11beta-HSD could possibly lead to an excess of GCS in the hepatocytes. Due to 5alpha-reductase activity this excess can be limited - on the level of CORT as well as of 11-DHC.


Subject(s)
3-Oxo-5-alpha-Steroid 4-Dehydrogenase/metabolism , Liver/enzymology , 11-beta-Hydroxysteroid Dehydrogenases , 5-alpha Reductase Inhibitors , Animals , Azasteroids/pharmacology , Corticosterone/analogs & derivatives , Corticosterone/metabolism , Enzyme Inhibitors/pharmacology , Finasteride/pharmacology , Hydrogen-Ion Concentration , Hydroxysteroid Dehydrogenases/metabolism , Kinetics , Rabbits
7.
J Perinat Med ; 27(4): 309-15, 1999.
Article in English | MEDLINE | ID: mdl-10560084

ABSTRACT

Our purpose was to elucidate why clinical studies have up to now failed to demonstrate a positive effect of TRH combined with glucocorticosteroids on fetal lung maturity. Morphological and biochemical lung maturation were determined by electron microscopy, choline incorporation, and surfactant-protein-A m-RNA synthesis in rat lung organoid cultures after exposure with a series of concentrations of dexamethasone, triiodothyronine, and dimethyl-isopropyl-thyronine. Thyroid hormones improved morphogenesis of lung histotypic structures but had a negative effect on surfactant synthesis whereas glucocorticosteroids had a positive effect on the surfactant synthesis but a negative effect on morphogenesis. The combination of both substances even had the most negative effect on morphogenesis. Since morphogenesis of lung histotypic structures is prerequisite for surfactant synthesis and secretion, we hypothesize that a sequential treatment of thyroid hormones to improve morphogenesis followed by the application of glucocorticosteroids might be an option to improve neonatal lung function.


Subject(s)
Dexamethasone/pharmacology , Glucocorticoids/pharmacology , Lung/embryology , Respiratory Distress Syndrome, Newborn/prevention & control , Thyronines/pharmacology , Triiodothyronine/pharmacology , Animals , Blotting, Northern , Female , Fetal Organ Maturity/drug effects , Humans , Infant, Newborn , Lung/drug effects , Lung/ultrastructure , Microscopy, Electron , Phosphatidylcholines/analysis , Phosphatidylcholines/biosynthesis , Pregnancy , Proteolipids/analysis , Proteolipids/biosynthesis , Pulmonary Surfactant-Associated Proteins , Pulmonary Surfactants/analysis , Pulmonary Surfactants/biosynthesis , Rats , Rats, Wistar
8.
Cancer Res ; 59(18): 4502-5, 1999 Sep 15.
Article in English | MEDLINE | ID: mdl-10493495

ABSTRACT

Cripto-1 (CR-1), a member of the epidermal growth factor-CFC peptide family, activates the ras/raf/mitogen-activated protein/extracellular signal-regulated kinase/mitogen-activated protein kinase pathway. In the present study, the role of CR-1 in the phosphatidylinositol 3'-kinase (PI3K)/AKT (protein kinase B)/glycogen synthase kinase 3beta (GSK-3beta)-dependent signaling pathway was evaluated in human SiHa cervical carcinoma cells. Our data demonstrate that CR-1 can enhance the tyrosine phosphorylation of the p85 regulatory subunit of PI3K and transiently induce the phosphorylation of AKT in a time- and dose-dependent manner. In addition, CR-1 was found to induce the phosphorylation of GSK-3beta. Phosphorylation of AKT and GSK-3beta by CR-1 can be blocked by LY294002, a specific inhibitor of PI3K, thus leading to apoptosis. Finally, the apoptotic effect of LY294002 can be partially rescued by exogenous CR-1. In summary, our data suggest that human CR-1 may function as a survival factor through a PI3K-dependent signaling pathway involving AKT and GSK-3beta.


Subject(s)
Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Epidermal Growth Factor , Membrane Glycoproteins , Neoplasm Proteins/physiology , Phosphatidylinositol 3-Kinases/metabolism , Protein Serine-Threonine Kinases , Proto-Oncogene Proteins/metabolism , Chromones/pharmacology , Culture Media, Serum-Free , Enzyme Inhibitors/pharmacology , Female , GPI-Linked Proteins , Glycogen Synthase Kinase 3 , Glycogen Synthase Kinases , Growth Substances/physiology , Humans , Intercellular Signaling Peptides and Proteins , Morpholines/pharmacology , Phosphorylation , Proto-Oncogene Proteins c-akt , Recombinant Proteins/metabolism , Transfection , Tumor Cells, Cultured , Uterine Cervical Neoplasms
9.
J Cancer Res Clin Oncol ; 125(8-9): 520-4, 1999.
Article in English | MEDLINE | ID: mdl-10480346

ABSTRACT

The HER2 protein, a member of the epidermal growth factor family, is encoded by the protooncogene c-erbB-2. Its overexpression, occurring in approximately one-third of all breast carcinomas, is associated with a poor prognosis. A humanized mouse antibody against HER2 has been developed by genetic engineering. Here an unspecific human IgG was connected to the recognizing mouse IgG fragment. The allergization typical for allogeneic antibodies does not take place in this context. The effectiveness of this antibody has been confirmed by two international prospective phase III trials that tested it alone and combined with chemotherapy. Both modes of application increased the response rates and the time to progression. Side-effects were rare except for a high rate of cardiac dysfunction when the antibody was combined with anthracyclines. The effectiveness and negligible side-effects of the chimeric antibody against HER2 (Herceptin) render it a valuable tool in the treatment of breast cancer.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Antineoplastic Agents/therapeutic use , Breast Neoplasms/therapy , Carcinoma, Ductal, Breast/therapy , Receptor, ErbB-2/immunology , Antibodies, Monoclonal, Humanized , Breast Neoplasms/chemistry , Breast Neoplasms/immunology , Breast Neoplasms/pathology , Carcinoma, Ductal, Breast/chemistry , Carcinoma, Ductal, Breast/immunology , Carcinoma, Ductal, Breast/secondary , Clinical Trials, Phase III as Topic , Female , Gene Expression Regulation, Neoplastic , Humans , Receptor, ErbB-2/analysis , Trastuzumab , Treatment Outcome , Up-Regulation
10.
Eur J Obstet Gynecol Reprod Biol ; 84(1): 69-74, 1999 May.
Article in English | MEDLINE | ID: mdl-10413230

ABSTRACT

OBJECTIVE: The aim of this prospective study was to assess erythropoiesis and test for functional iron deficiency in the postpartum period using quantitative red blood cell analysis. STUDY DESIGN: Parameters were determined on admission for delivery and postpartum from 82 obstetric patients at Zurich University Hospital: full blood count, hypochromic and microcytic red cells, reticulocyte count (including subsets), reticulocyte mean corpuscular volume, reticulocyte mean hemoglobin content and reticulocyte mean corpuscular hemoglobin concentration. RESULTS: Microcytic cells increased from 0.9% prepartum to 1.4% on day 42 postpartum; hypochromic cells decreased from 4.3 to 1.9%; reticulocyte mean corpuscular volume decreased from 134 to 125 fl; reticulocyte mean hemoglobin content was unchanged. CONCLUSION: To our knowledge, this is the first medium scale application of quantitative red blood cell analysis to normal pre- and postpartum women. Our data show no evidence of functional iron deficiency or increased erythropoiesis in the postpartum period.


Subject(s)
Erythropoiesis/physiology , Iron Deficiencies , Reticulocytes/physiology , Adult , Blood Cell Count , Female , Flow Cytometry , Hematocrit , Hemoglobins/analysis , Humans , Postpartum Period , Pregnancy , Prospective Studies
11.
Eur J Obstet Gynecol Reprod Biol ; 84(1): 111-3, 1999 May.
Article in English | MEDLINE | ID: mdl-10413240

ABSTRACT

The coincidence of HELLP syndrome and cortical blindness is an uncommon but very dramatic event, for the patient as well as the obstetrician. This report describes the first case of HELLP-syndrome-associated cortical blindness occuring suddenly in the third stage of labour. There were only modest correlates of cortical blindness in cerebral CT, MRI and angiography findings, but no signs of a posterior leucoencephalopathy syndrome. Mother and baby were discharged from hospital to outpatient care in good health on the 12th day.


Subject(s)
Blindness, Cortical/complications , HELLP Syndrome/complications , Labor, Obstetric/physiology , Adult , Anti-Arrhythmia Agents/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Anticonvulsants/therapeutic use , Antihypertensive Agents/therapeutic use , Apgar Score , Blindness, Cortical/physiopathology , Blood Pressure , Diazepam/therapeutic use , Dihydralazine/therapeutic use , Electroencephalography , Female , HELLP Syndrome/physiopathology , Histamine H2 Antagonists/therapeutic use , Humans , Infant, Newborn , Liver/enzymology , Magnesium Sulfate/therapeutic use , Magnetic Resonance Imaging , Nimodipine/therapeutic use , Prednisolone/therapeutic use , Pregnancy , Ranitidine/therapeutic use
12.
Horm Metab Res ; 31(1): 8-13, 1999 Jan.
Article in English | MEDLINE | ID: mdl-10077342

ABSTRACT

Epidermal growth factor (EGF), a mitogenic polypeptide that binds to cell surface receptors, is an important regulator of cell differentiation and fetal lung surfactant synthesis, and may be used as a potential novel therapeutic agent in prematurity. Nevertheless, the distinct role in lung development and its mechanisms of action are not well understood. We investigated in vivo the systemic effect of intrafetally administered EGF (200 ng/g fetal body weight) and maternally administered dexamethasone (DEXA; 0.2 and 2.0mg/kg maternal body weight) on the activity of important enzymes of the phospholipid synthesis in the fetal rat lung and liver: choline kinase (EC 2.7.1.32), cholinephosphate cytidyltransferase (EC 2.7.7.15), choline phosphotransferase (EC 2.7.8.2), lysolecithin acyltransferase (EC 2.3.1.23) and glycerolphosphate phosphatidyltransferase (EC 2.7.8.5). Additionally, in vivo and in vitro effects of DEXA on EGF receptor synthesis, and the effects of EGF on protein content and morphogenesis of the fetal rat lung organoid culture, were evaluated. Whereas DEXA induced the activity of all investigated enzymes of phospholipid synthesis and increased EGF receptor synthesis, EGF has no effects on the enzymes, either in vivo or in vitro. EGF enhanced protein synthesis and morphogenesis in vitro. With respect to our data and the literature, we hypothesize that DEXA and EGF may act on different cellular sides. Whereas glucocorticoids induce surfactant phospholipid synthesis, EGF should be more involved in cell proliferation and morphogenesis.


Subject(s)
Epidermal Growth Factor/pharmacology , Liver/embryology , Lung/embryology , Phospholipids/biosynthesis , Animals , Dexamethasone/administration & dosage , Dexamethasone/pharmacology , ErbB Receptors/drug effects , Female , Glucocorticoids/administration & dosage , Glucocorticoids/pharmacology , Liver/drug effects , Liver/enzymology , Lung/drug effects , Lung/enzymology , Maternal-Fetal Exchange , Organ Culture Techniques , Phosphatidylcholines/biosynthesis , Phosphatidylglycerols/biosynthesis , Pregnancy , Rats , Rats, Wistar
13.
Lasers Med Sci ; 14(2): 91-6, 1999 Jun.
Article in English | MEDLINE | ID: mdl-24519162

ABSTRACT

The disappointing results with either surgery alone and/or chemotherapy in the treatment of malignant ovarian tumours have led to an increased interest in additional treatment schedules. Photodynamic therapy (PDT), a modality involving the use of a photosensitising drug and activating light, is being used increasingly as a local treatment for neoplastic lesions. The synthesis and evaluation of new photosensitisers for the treatment of gynaecological lesions and malignancies continues to be an active area of investigation for proper application of the photodynamic process in the gynaecological field. The effect of PDT using methylene blue (free and combined with liposomes) as a photosensitiser for treating human ovarian malignant tumours cultivated on the chorioallantoic membrane was evaluated. Two days after PDT, the treated implanted tumours were markedly decreased in size. Areas of necrosis with black coloration, dryness and eschar formation were observed. Five days after PDT, tumour remission was clearly observed in all the treated tumours. Photodynamic therapy using methylene blue (aqueous and coupled with liposomes) is effective for treating the ovarian malignancies and it will be capable of achieving complete eradication of visible tumours in patients with superficial lesions.

14.
Lasers Med Sci ; 14(2): 136-42, 1999 Jun.
Article in English | MEDLINE | ID: mdl-24519169

ABSTRACT

The effect of laser-induced thermotherapy (LITT) as a palliative method for treatment of patients with local recurrence of breast cancer is investigated. This report describes the use of interstitial laser photocoagulation to manage such lesions. The interstitial laser applications were performed in seven women with locally recurrent breast carcinoma on the chest wall after mastectomy. All patients had been heavily pretreated with conventional modes of therapy (radiotherapy, chemotherapy, hormonal therapy, surgical resection). A Nd:YAG laser with a wavelength of 1064 nm was used to heat the lesions. Heat expansion was controlled digitally and monitored by ultrasonography and colour-coded duplex sonography (CCDS). In five women this minimally invasive method enabled the precise coagulation of the subcutaneous tumour without destruction of the skin or ulceration, although these areas had been pretreated by irradiation up to 60 Gy. In two patients with extensive multiple metastases and with skin infiltration, secondary skin ulceration and delayed healing was observed. For palliative reasons, LITT under CCDS guide can aid in local control of chest wall recurrence following mastectomy in selected patients.

15.
Eur J Obstet Gynecol Reprod Biol ; 80(2): 273-4, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9846683

ABSTRACT

Gastric cancer is unusual during pregnancy. The diagnosis may be delayed because specific symptoms are similar to typical pregnancy associated complaints. Our therapeutic management with palliative chemotherapy and later gastrectomy differs from other known cases, where surgical resection has been the treatment of choice. Surgery appears to have no influence on the prognosis of gastric cancer patients with hepatic metastases.


Subject(s)
Pregnancy Complications, Neoplastic/diagnosis , Stomach Neoplasms/diagnosis , Vomiting , Adult , Cesarean Section , Fatal Outcome , Female , Gastrectomy , Gestational Age , Humans , Liver Neoplasms/diagnosis , Liver Neoplasms/diagnostic imaging , Liver Neoplasms/secondary , Magnetic Resonance Imaging , Pregnancy , Pregnancy Complications, Neoplastic/therapy , Stomach Neoplasms/diagnostic imaging , Stomach Neoplasms/therapy , Ultrasonography
16.
J Reprod Med ; 43(7): 598-600, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9693413

ABSTRACT

BACKGROUND: Sarcomas of the fallopian tube are rarities in gynecologic oncology, consisting of < 1% of all genital sarcomas. CASE: A 70-year-old woman with a stage I malignant mixed müllerian tumor (MMMT) (International Federation of Gynecology and Obstetrics classification of fallopian tube carcinomas) did not undergo radical surgery or adjuvant treatment because of the patient's refusal of them. The patient underwent only abdominal hysterectomy with bilateral salpingo-oophorectomy. She was discharged feeling well and without abnormal clinical findings. Sixty months after primary surgery there were no signs of recurrence. CONCLUSION: This case suggests the possibility of a good prognosis in early-stage MMMT, especially if there is no deep infiltration of the fallopian tube muscle layer or lymphatic permeation and if the peritoneal cytology is negative. The important feature of this report is the five year disease-free survival after nonradical surgery for prognostically favorable MMMT.


Subject(s)
Fallopian Tube Neoplasms/surgery , Mixed Tumor, Mullerian/surgery , Aged , Disease-Free Survival , Fallopian Tube Neoplasms/pathology , Female , Humans , Hysterectomy , Minimally Invasive Surgical Procedures , Mixed Tumor, Mullerian/pathology , Ovariectomy , Prognosis
17.
18.
Eur J Contracept Reprod Health Care ; 3(1): 45-50, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9678073

ABSTRACT

BACKGROUND AND OBJECTIVES: There are currently groups of women using high-dose estrogen contraceptive pills, especially in the developing countries. The aim of this study was to determine the correlation between the duration of contraceptive pill intake, the dose of steroid contained in the contraceptive pills and the incidence and degree of serum prolactin level elevation in those women. STUDY DESIGN: This study was conducted in 100 contraceptive pill users. Women were randomly selected for this study with an age range from 19 to 35 years and duration of contraceptive pill intake from 6 to 120 months. Cases were classified into two groups. The first group (50 cases) were taking high-dose estrogen pills (50 micrograms) and the second group (50 cases) were taking low-dose estrogen pills (30 micrograms). RESULTS: The results of the present study showed that there was a significant elevation in serum prolactin level in both groups, with a more significant elevation in the high-dose pill users. CONCLUSIONS: There is a positive relationship between serum prolactin level and the duration of pill intake and their steroid content, and this relationship is not related to the age and parity of the women. The groups of women studied are scheduled for follow-up to determine if there is any future drawback which results as a consequence of the developed hyperprolactinemia. Prolactin determination should be considered for all women prior to pill intake. This determination of serum prolactin level prior to pill use will be useful in the evaluation of the future relationship between the estrogen content of the pills and the later development of hyperprolactinemia.


Subject(s)
Contraceptives, Oral, Hormonal/adverse effects , Estradiol Congeners/adverse effects , Ethinyl Estradiol/adverse effects , Hyperprolactinemia/chemically induced , Levonorgestrel , Progesterone Congeners , Adult , Age Distribution , Chemistry, Pharmaceutical , Contraceptives, Oral, Hormonal/analysis , Estradiol Congeners/analysis , Ethinyl Estradiol/analysis , Female , Humans , Hyperprolactinemia/blood , Incidence , Levonorgestrel/analysis , Parity , Progesterone Congeners/analysis , Time Factors
19.
Fetal Diagn Ther ; 13(1): 35-8, 1998.
Article in English | MEDLINE | ID: mdl-9605614

ABSTRACT

Advances in ultrasound technology and sonographer's experience lead to the description of many rare syndromes and malformations through prenatal diagnosis. Diaphragmatic hernia is a rather common malformation but can be an indicator of different syndromes. We report the prenatal diagnosis of lethal multiple pterygium syndrome type II which has been established in the 34th week of pregnancy. The sonographically detectable symptoms consisted of polyhydramnios, hygroma colli, diaphragmatic hernia, scoliosis, short forearms, hypokinesia of the fetus and pterygia over the large joints. Labour was induced in the 34th week of pregnancy; the neonate died shortly after vaginal delivery as a result of the pulmonary hypoplasia. A multidisciplinary approach in prenatal assessment may help to clarify difficult diagnostic problems and may be of direct benefit for the pregnant patient.


Subject(s)
Abnormalities, Multiple/diagnostic imaging , Ultrasonography, Prenatal , Adult , Fatal Outcome , Female , Forearm/abnormalities , Gestational Age , Hernia, Diaphragmatic/diagnostic imaging , Humans , Joints/abnormalities , Labor, Induced , Lymphangioma, Cystic/diagnostic imaging , Polyhydramnios/diagnostic imaging , Pregnancy , Scoliosis/diagnostic imaging , Syndrome
20.
J Endocrinol ; 155(1): 171-80, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9390020

ABSTRACT

This in vitro study on MCF-7 and ZR-75-1 breast cancer cells showed that the antiproliferative action of glucocorticosteroids (GCS) on breast cancer cells is weakened by a high oxidative activity of 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD; EC 1.1.1.146): both endogenic as well as synthetic GCS (dexamethasone, prednisolone) were metabolised to hormonally inactive 11-dehydro metabolites. This enzymatic shield protected the breast cancer cells from the antiproliferative action of GCS. Continuous exposure of breast cancer cells to GCS resulted in enhanced 11 beta-HSD activity. The intracellular GCS concentration was further reduced by this feedback and thus the antiproliferative effect was additionally weakened. These mechanisms of GCS deactivation could be influenced by inhibiting 11 beta-HSD with the liquorice compound glycyrrhetinic acid (GLY). In MCF-7 and ZR-75-1 cultures the antiproliferative effect of GCS was significantly increased by GLY.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Breast Neoplasms/drug therapy , Glucocorticoids/therapeutic use , Glycyrrhetinic Acid/therapeutic use , Hydroxysteroid Dehydrogenases/antagonists & inhibitors , 11-beta-Hydroxysteroid Dehydrogenases , Administration, Topical , Aminoglutethimide/pharmacology , Analysis of Variance , Antineoplastic Agents, Hormonal/pharmacology , Aromatase Inhibitors , Breast/enzymology , Breast Neoplasms/enzymology , Carcinoma, Intraductal, Noninfiltrating/drug therapy , Carcinoma, Intraductal, Noninfiltrating/enzymology , Cell Division/drug effects , Cells, Cultured , Dexamethasone/metabolism , Dexamethasone/therapeutic use , Female , Glucocorticoids/metabolism , Humans , Hydroxysteroid Dehydrogenases/metabolism , Prednisolone/metabolism , Prednisolone/therapeutic use , Tamoxifen/pharmacology , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...